PF
Therapeutic Areas
Can Fite Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Piclidenoson (CF101) | Plaque Psoriasis | Phase III |
| Namodenoson (CF102) | Hepatocellular Carcinoma | Phase IIb/III |
| CF602 | Erectile Dysfunction | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Piclidenoson (CF101) | Plaque Psoriasis | Phase III |
| Namodenoson (CF102) | Hepatocellular Carcinoma | Phase IIb/III |
| CF602 | Erectile Dysfunction | Preclinical |